Skip to main navigation Skip to search Skip to main content
2 Scopus citations

Abstract

While it is clear that platelets interact with viruses, the ramifications and mechanisms of those interactions are still being defined for each type of viral infection. HIV/AIDS+ represents a potentially unique example of how viremia affects platelets since the increasing efficacy of antiretroviral therapeutics (ART) has made it a chronic disease that increases the risk of cardiovascular disease. In this opinion article, we discuss some of the open questions about how platelets interact with HIV. What happens to a virion once it binds a platelet? What is the nature of virus-induced platelet activation? Are platelets a normal part of the immune response to viremia that has been co-opted to increase the spread of HIV? The answers to these and similar questions will help define how platelet-directed therapeutics might be used in treating HIV/AIDS+ patients.

Original languageEnglish
Pages (from-to)208-211
Number of pages4
JournalPlatelets
Volume33
Issue number2
DOIs
StatePublished - 2022

Bibliographical note

Publisher Copyright:
© 2022 Taylor & Francis Group, LLC.

Funding

This work is supported by grants from the National Institutes of Health, National Heart, Lung, and Blood Institute (HL56652, HL138179, and HL150818), and a Department of Veterans Affairs Merit Award to S.W.W.

FundersFunder number
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)R01HL056652, HL138179, HL150818
U.S. Department of Veterans Affairs

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • AIDS
    • HIV
    • endocytosis
    • platelets
    • viremia

    ASJC Scopus subject areas

    • Hematology

    Fingerprint

    Dive into the research topics of 'Platelet-HIV: interactions and their implications'. Together they form a unique fingerprint.

    Cite this